MED 27 is an inhibitor of thromboxane synthase and thromboxane A2 receptors . MED 27 can inhibit rat platelet aggregation at doses much lower than that of Acetylsalicylic acid ( HY-14654 ).
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Prostaglandin Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.